Peron Kelly Abdo, Scott Marina Cançado Passarelli, Soeiro Tracy Lima Tavares, do Amaral Jônatas Bussador, Chandrasekhar Sujana S, de Oliveira Penido Norma
Department of Otolaryngology Head and Neck Surgery, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.
ENT and Allergy Associates, LLP, New York, NY, United States.
Front Neurol. 2024 Sep 4;15:1415068. doi: 10.3389/fneur.2024.1415068. eCollection 2024.
Sudden sensorineural hearing loss (SSNHL) is an otological emergency that requires prompt recognition and intervention to prevent devastating impacts on people's lives. During the COVID-19 pandemic, sensory deprivations have been reported in patients positive for SARS-CoV-2 virus, including deleterious effects on the auditory pathway. This study aims to describe the audiological profile of individuals with SSNHL during the COVID-19 pandemic and to correlate hearing recovery in subgroups of individuals with or without COVID-19.
Prospective cohort including patients diagnosed with SSNHL evaluated in a tertiary care center between March 2020 and September 2022. Hearing loss was confirmed with pure-tone and speech audiometry, with Speech Recognition Threshold (SRT) and word recognition score (WRS). Audiometric testing was performed at the moment of diagnosis, then 7, 30 and 120 days after diagnosis. The average degree of hearing loss was assessed by calculating the 4-frequency pure tone average (4fPTA). The investigation of COVID-19 included RT-PCR technique for the SARS-CoV-2 virus and collection of information regarding disease severity. A statistical analysis was performed using an analysis of covariance (ANCOVA) model to compare the 4fPTA between the four groups (with and without a history of COVID-19, unilateral and bilateral cases) at the end of the follow-up period.
Fifty-two patients with SSNHL were assessed, 40 (76.9%) with unilateral and 12 (23.1%) with bilateral hearing loss, totaling 64 ears included. Of those, 15 (28.8%) patients tested positive for SARS-CoV-2 and were symptomatic for COVID-19. Of all unilateral cases, 22.5% were seropositive and showed symptoms of COVID-19, a number that increased to 50% for bilateral cases. Comparing the COVID-19 positive groups, individuals with unilateral SSNHL went from 40 dB as their average 4fPTA at onset to 20 dB as their average 4fPTA after 120 days, whereas those with bilateral SSNHL went from an initial average of 60 dB to a final average of 66 dB. Although the 4fPTA value of individuals with unilateral SSNHL improved in 7 days, the mean values showed no significant difference between positive and negative groups. There was a higher incidence of bilateral simultaneous SSNHL in patients who had not been vaccinated against COVID-19 and who presented with symptoms of severe COVID-19.
Infection with SARS-CoV-2 resulted in more severe SSNHL, in bilateral SSNHL, and in poorer recovery from SSNHL in bilateral cases. Bilateral SSNHL was seen more frequently in patients who had not received vaccination against COVID-19.
突发性感音神经性听力损失(SSNHL)是一种耳科急症,需要及时识别和干预,以防止对人们的生活造成毁灭性影响。在新冠疫情期间,有报告称感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的患者出现了感觉剥夺现象,包括对听觉通路的有害影响。本研究旨在描述新冠疫情期间SSNHL患者的听力特征,并比较有或无新冠感染的亚组患者的听力恢复情况。
前瞻性队列研究,纳入2020年3月至2022年9月在一家三级医疗中心接受评估的确诊为SSNHL的患者。通过纯音听力计和言语测听法,以及言语识别阈值(SRT)和单词识别得分(WRS)来确诊听力损失。在诊断时、诊断后7天、30天和120天进行听力测试。通过计算4频率纯音平均值(4fPTA)来评估听力损失的平均程度。对新冠病毒的调查包括针对SARS-CoV-2病毒的逆转录聚合酶链反应(RT-PCR)技术以及收集有关疾病严重程度的信息。使用协方差分析(ANCOVA)模型进行统计分析,以比较随访期末四组(有或无新冠病史、单侧和双侧病例)的4fPTA。
共评估了52例SSNHL患者,其中40例(76.9%)为单侧听力损失,12例(23.1%)为双侧听力损失,共计64耳。其中,15例(28.8%)患者SARS-CoV-2检测呈阳性且有新冠症状。在所有单侧病例中,22.5%的患者血清学呈阳性且有新冠症状,双侧病例中这一比例增至50%。比较新冠阳性组,单侧SSNHL患者的平均4fPTA从发病时的40dB降至120天后的20dB,而双侧SSNHL患者则从最初的平均60dB升至最终的平均66dB。虽然单侧SSNHL患者的4fPTA值在7天内有所改善,但阳性和阴性组的平均值之间无显著差异。未接种新冠疫苗且出现严重新冠症状的患者中,双侧同时发生SSNHL的发生率更高。
感染SARS-CoV-2导致更严重的SSNHL、双侧SSNHL,且双侧病例中SSNHL的恢复较差。未接种新冠疫苗的患者中双侧SSNHL更为常见。